NeuroXess advances Chinese BCI with 50+ human implants and real-time Mandarin speech decoding
Summary
NeuroXess, a Shanghai-based brain-computer interface company, has successfully completed over 50 BCI human implants and achieved breakthrough real-time Mandarin speech decoding. The company's integrated battery implant design represents a significant advancement over earlier systems that relied on external hardware, achieving 71% accuracy when decoding 142 commonly used Chinese syllables within 100 milliseconds.
Why it matters
NeuroXess is rapidly emerging as China's answer to Neuralink, with more implants completed than its American rival. The company's real-time Chinese speech decoding capability represents a critical milestone for BCI technology in tonal languages, with implications for millions of patients with speech disabilities. China has listed BCIs as a core strategic technology alongside quantum computing and nuclear fusion.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial